MLTX
MoonLake Immunotherapeutics
-0.12 (-0.92%)12.35USD413K成交股數1.1B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 9 · 6.1M · 3 |
| 其中 10b5-1 計畫賣出 | 9 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 644M |
| 近 180 天 淨額 | −644M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 | 07-29 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.1K | 20.00 | 22K | 2.7M | SEC |
| 2026-07-22 | 07-23 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.4K | 20.00 | 49K | 2.7M | SEC |
| 2026-07-21 | 07-23 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 50.0K | 20.02 | 1.0M | 2.7M | SEC |
| 2026-07-20 | 07-21 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 43.7K | 20.09 | 878K | 2.8M | SEC |
| 2026-07-15 | 07-20 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 16.1K | 20.01 | 322K | 2.8M | SEC |
| 2026-07-10 | 07-13 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出(10b5-1) | 68.3K | 20.02 | 1.4M | 2.8M | SEC |
| 2026-07-09 | 07-13 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出(10b5-1) | 33.9K | 20.01 | 679K | 2.8M | SEC |
| 2026-07-01 | 07-02 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出(10b5-1) | 47.8K | 20.03 | 957K | 2.9M | SEC |
| 2026-06-22 | 06-23 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 39.1K | 22.04 | 862K | 1.1M | SEC |
| 2026-06-18 | 06-18 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.8K | 19.60 | 55K | 1.2M | SEC |
| 2026-06-17 | 06-18 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 15.1K | 19.68 | 297K | 1.2M | SEC |
| 2026-06-17 | 06-17 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 50.0K | 19.43 | 972K | 2.8M | SEC |
| 2026-06-16 | 06-17 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 50.0K | 18.70 | 935K | 2.9M | SEC |
| 2026-06-15 | 06-17 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 50.0K | 18.89 | 945K | 2.9M | SEC |
| 2026-05-11 | 05-13 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.7K | 20.02 | 273K | 1.2M | SEC |
| 2026-04-14 | 04-16 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.4K | 19.56 | 47K | 1.2M | SEC |
| 2026-04-13 | 04-14 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出 | 51.9K | 18.23 | 946K | 2.9M | SEC |
| 2026-04-10 | 04-14 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出 | 98.1K | 18.41 | 1.8M | 3.0M | SEC |
| 2026-04-10 | 04-10 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.9K | 19.51 | 38K | 1.2M | SEC |
| 2026-04-09 | 04-10 | Bodenstedt Matthias | Chief Financial Officer | S 公開市場賣出(10b5-1) | 85.9K | 18.94 | 1.6M | 1.2M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND L P | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF INC/IL | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF INC/IL | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BVF INC/IL | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF PARTNERS L P/IL | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF PARTNERS L P/IL | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF GP HOLDINGS LLC | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF GP HOLDINGS LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND II LP | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND II LP | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BVF GP HOLDINGS LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BVF PARTNERS L P/IL | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BVF II GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BVF II GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF I GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF I GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF Partners OS Ltd. | Director,Other | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF Partners OS Ltd. | Director,Other | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND L P | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND II LP | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | Biotechnology Value Trading Fund OS LP | Director,Other | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF I GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | Biotechnology Value Trading Fund OS LP | Director,Other | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | Biotechnology Value Trading Fund OS LP | Director,Other | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | LAMPERT MARK N | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | BVF II GP LLC | Director,TenPercentOwner | S 公開市場賣出 | 249K | 16.79 | 4.2M | 1.0M | SEC |
| 2026-03-31 | 04-02 | LAMPERT MARK N | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | BIOTECHNOLOGY VALUE FUND L P | Director,TenPercentOwner | S 公開市場賣出 | 1.6M | 16.79 | 26.3M | 6.6M | SEC |
| 2026-03-31 | 04-02 | LAMPERT MARK N | Director,TenPercentOwner | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-03-31 | 04-02 | BVF Partners OS Ltd. | Director,Other | S 公開市場賣出 | 1.9M | 16.79 | 32.4M | 8.3M | SEC |
| 2026-01-07 | 01-09 | Bodenstedt Matthias | Chief Financial Officer | A 獲配股票 | 354K | – | – | 1.3M | SEC |
| 2025-12-19 | 12-22 | Santos da Silva Jorge | Chief Executive Officer | C 轉換 | 196K | – | – | 3.1M | SEC |
| 2025-12-19 | 12-22 | Bodenstedt Matthias | Chief Financial Officer | D 處分 | 294K | – | – | 0 | SEC |
| 2025-12-19 | 12-22 | Bodenstedt Matthias | Chief Financial Officer | C 轉換 | 294K | – | – | 922K | SEC |
| 2025-12-19 | 12-22 | Santos da Silva Jorge | Chief Executive Officer | D 處分 | 196K | – | – | 0 | SEC |
| 2025-12-19 | 12-22 | Reich Kristian | Chief Scientific Officer | D 處分 | 35.4K | – | – | 0 | SEC |
| 2025-12-19 | 12-22 | Reich Kristian | Chief Scientific Officer | C 轉換 | 35.4K | – | – | 35.4K | SEC |
| 2025-12-09 | 12-10 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出 | 72.9K | 14.43 | 1.1M | 0 | SEC |
| 2025-12-09 | 12-10 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出 | 70.0K | 14.49 | 1.0M | 2.9M | SEC |
| 2025-12-08 | 12-10 | Santos da Silva Jorge | Chief Executive Officer | S 公開市場賣出 | 130K | 15.08 | 2.0M | 2.9M | SEC |
| 2025-12-08 | 12-10 | Reich Kristian | Chief Scientific Officer | S 公開市場賣出 | 130K | 15.08 | 2.0M | 72.9K | SEC |
| 2025-10-08 | 10-09 | Bodenstedt Matthias | Chief Financial Officer | P 公開市場買進 | 10.9K | 9.09 | 99K | 628K | SEC |
| 2025-09-30 | 10-01 | Cormorant Global Healthcare Master Fund, LP | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-30 | 10-01 | Chen Bihua | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-30 | 10-01 | Cormorant Private Healthcare Fund III LP | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-30 | 10-01 | Cormorant Private Healthcare Fund IV LP | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-30 | 10-01 | Cormorant Private Healthcare Fund II, LP | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-30 | 10-01 | Cormorant Asset Management, LP | Other | S 公開市場賣出 | 5.8K | 6.96 | 41K | 2.0M | SEC |
| 2025-09-29 | 10-01 | Cormorant Private Healthcare Fund II, LP | Other | S 公開市場賣出 | 3.4M | 7.58 | 25.7M | 4.8M | SEC |
| 2025-09-29 | 10-01 | Cormorant Private Healthcare Fund II, LP | Other | S 公開市場賣出 | 70.7K | 9.38 | 664K | 8.4M | SEC |
| 2025-09-29 | 10-01 | Cormorant Global Healthcare Master Fund, LP | Other | S 公開市場賣出 | 2.8M | 6.61 | 18.5M | 2.0M | SEC |
| 2025-09-29 | 10-01 | Cormorant Global Healthcare Master Fund, LP | Other | S 公開市場賣出 | 3.4M | 7.58 | 25.7M | 4.8M | SEC |
| 2025-09-29 | 10-01 | Cormorant Global Healthcare Master Fund, LP | Other | S 公開市場賣出 | 232K | 8.40 | 2.0M | 8.2M | SEC |
| 2025-09-29 | 10-01 | Cormorant Global Healthcare Master Fund, LP | Other | S 公開市場賣出 | 70.7K | 9.38 | 664K | 8.4M | SEC |
| 2025-09-29 | 10-01 | Chen Bihua | Other | S 公開市場賣出 | 2.8M | 6.61 | 18.5M | 2.0M | SEC |
| 2025-09-29 | 10-01 | Chen Bihua | Other | S 公開市場賣出 | 3.4M | 7.58 | 25.7M | 4.8M | SEC |
| 2025-09-29 | 10-01 | Chen Bihua | Other | S 公開市場賣出 | 232K | 8.40 | 2.0M | 8.2M | SEC |
| 2025-09-29 | 10-01 | Cormorant Private Healthcare Fund II, LP | Other | S 公開市場賣出 | 232K | 8.40 | 2.0M | 8.2M | SEC |
| 2025-09-29 | 10-01 | Chen Bihua | Other | S 公開市場賣出 | 70.7K | 9.38 | 664K | 8.4M | SEC |
| 2025-09-29 | 10-01 | Cormorant Asset Management, LP | Other | S 公開市場賣出 | 2.8M | 6.61 | 18.5M | 2.0M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BVF INC/IL | 16.0M | 312M | 新進 | 新進 |
| Deep Track Capital, LP | 7.0M | 136M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 3.4M | 65.5M | 新進 | 新進 |
| Cormorant Asset Management, LP | 3.2M | 62.4M | 新進 | 新進 |
| Jupiter Topco LLC | 3.1M | 60.1M | 新進 | 新進 |
| Logos Global Management LP | 2.7M | 52.1M | 新進 | 新進 |
| Weiss Asset Management LP | 2.6M | 50.3M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 2.0M | 38.4M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.7M | 33.4M | 新進 | 新進 |
| MPM BIOIMPACT LLC | 1.6M | 31.3M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.4M | 27.6M | 新進 | 新進 |
| Vivo Capital, LLC | 1.4M | 27.3M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 1.2M | 22.6M | 新進 | 新進 |
| BlackRock, Inc. | 1.1M | 21.3M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 913K | 17.8M | 新進 | 新進 |
| GREAT POINT PARTNERS LLC | 856K | 16.7M | 新進 | 新進 |
| JANE STREET GROUP, LLC | 853K | 16.6M | 新進 | 新進 |
| Candriam S.C.A. | 770K | 15.0M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 752K | 14.6M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 751K | 14.6M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 750K | 14.6M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 643K | 12.5M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 636K | 12.4M | 新進 | 新進 |
| MORGAN STANLEY | 564K | 11.0M | 新進 | 新進 |
| MARSHALL WACE, LLP | 550K | 10.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 173 +26 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 173 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 73.4M · 86.3% |
| 合計季末市值 | 1.3B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.1M |
|---|---|
| 與上期比 | +4.8% |
| 佔流通股數 | 8.39% |
| 日均成交量 | 1.1M |
| 回補天數 | 6.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.1M | +4.8% | 8.39% | 1.1M | 6.7 |
| 2026-08-14 | 6.8M | +19.2% | 8.01% | 1.6M | 4.2 |
| 2026-07-31 | 5.7M | -9.7% | 6.72% | 865K | 6.6 |
| 2026-07-15 | 6.3M | -3.4% | 7.44% | 1.3M | 5.0 |
| 2026-06-30 | 6.6M | +23.3% | 7.71% | 1.9M | 3.5 |
| 2026-06-15 | 5.3M | -4.5% | 6.25% | 737K | 7.2 |
| 2026-05-29 | 5.6M | +1.8% | 6.54% | 804K | 6.9 |
| 2026-05-15 | 5.5M | -13.5% | 6.42% | 1.1M | 5.0 |
| 2026-04-30 | 6.3M | -5.0% | 7.43% | 683K | 9.3 |
| 2026-04-15 | 6.7M | -14.2% | 7.82% | 1.6M | 4.2 |
| 2026-03-31 | 7.8M | +6.1% | 9.11% | 997K | 7.8 |
| 2026-03-13 | 7.3M | +3.9% | 8.59% | 800K | 9.1 |
| 2026-02-27 | 7.0M | -3.2% | 8.27% | 1.6M | 4.4 |
| 2026-02-13 | 7.3M | +3.6% | 8.54% | 1.1M | 6.9 |
| 2026-01-30 | 7.0M | -2.3% | 8.24% | 1.4M | 5.0 |
| 2026-01-15 | 7.2M | +24.3% | 8.44% | 5.6M | 1.3 |
| 2025-12-31 | 5.8M | +18.0% | 6.79% | 1.2M | 4.9 |
| 2025-12-15 | 4.9M | +14.6% | 5.75% | 2.0M | 2.5 |
| 2025-11-28 | 4.3M | +10.7% | 5.02% | 2.0M | 2.2 |
| 2025-11-14 | 3.9M | -21.4% | 4.53% | 2.3M | 1.7 |
| 2025-10-31 | 4.9M | +0.3% | 5.77% | 2.8M | 1.8 |
| 2025-10-15 | 4.9M | -15.3% | 5.75% | 9.8M | 1.0 |
| 2025-09-30 | 5.8M | +16.6% | 6.78% | 11.2M | 1.0 |
| 2025-09-15 | 4.9M | -4.4% | 5.81% | 829K | 6.0 |
| 2025-08-29 | 5.2M | -3.5% | 6.08% | 432K | 12.0 |
| 2025-08-15 | 5.4M | -12.5% | 6.31% | 410K | 13.1 |